Florus C de Jong

8PUBLICATIONS
30CO-AUTHORS
Peripheral nervous systemCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 01, 2026
Stromal innervation is prognostic in non-muscle-invasive bladder cancer and predicted by a distinct microenvironmental transcriptomic signature.

|Mar 28, 2026
Spatial Immune Profiling and AI-Based Classifiers Identify Predictors of BCG Therapy Outcomes in High-Risk Non-Muscle-Invasive Bladder Cancer.

Melinda Lillesand, Marie Austdal, Jakub Mroz

|Jan 03, 2025
PD-L1 expression in high-risk non-muscle invasive bladder cancer is not a biomarker of response to BCG.

Florus C de Jong, Vebjørn Kvikstad, Robert F Hoedemaeker

|Sep 26, 2024
Characterization of FGFR Alterations and Activation in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer.

Joel R Eisner, Florus C de Jong, Yoichiro Shibata

|Aug 02, 2024
Molecular biomarkers of progression in non-muscle-invasive bladder cancer - beyond conventional risk stratification.

Mitchell Olislagers, Florus C de Jong, Vera C Rutten

|May 24, 2023
Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guérin.

Florus C de Jong, Teemu D Laajala, Robert F Hoedemaeker

Pageof 2

Frequent Collaborators

2 joint publications

Tahlita C M Zuiverloon

2 joint publications

Kimberly R Jordan

2 joint publications

Tahlita C M Zuiverloon

2 joint publications

Emiel A M Janssen